94 related articles for article (PubMed ID: 9100619)
1. DCC expression and prognosis in colorectal cancer.
Banerjee AK
Lancet; 1997 Apr; 349(9057):968. PubMed ID: 9100619
[No Abstract] [Full Text] [Related]
2. [DCC changes and prognosis in colorectal carcinoma].
Fiocca R
Pathologica; 1998 Feb; 90(1):79-80. PubMed ID: 9628983
[No Abstract] [Full Text] [Related]
3. The DCC protein and prognosis in colorectal cancer.
Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
[TBL] [Abstract][Full Text] [Related]
4. Correlating clinical outcome with molecular events in colorectal cancer.
Pasricha P
Gastroenterology; 1997 Jul; 113(1):360-1. PubMed ID: 9207303
[No Abstract] [Full Text] [Related]
5. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.
Popat S; Houlston RS
Eur J Cancer; 2005 Sep; 41(14):2060-70. PubMed ID: 16125380
[TBL] [Abstract][Full Text] [Related]
7. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
8. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
9. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
Kato M; Ito Y; Kobayashi S; Isono K
Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
[TBL] [Abstract][Full Text] [Related]
10. [Biomolecular prognostic factors in colorectal cancer].
Zorcolo L
Chir Ital; 2006; 58(6):733-42. PubMed ID: 17190278
[TBL] [Abstract][Full Text] [Related]
11. The DCC gene and colorectal cancer: the story is more complex.
Beggs AD; Abulafi M; Hodgson SV
Colorectal Dis; 2008 Jul; 10(6):630. PubMed ID: 18266884
[No Abstract] [Full Text] [Related]
12. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
13. Low frequency and late occurrence of p53 and dcc aberrations in colorectal tumours.
Froggatt NJ; Leveson SH; Garner RC
J Cancer Res Clin Oncol; 1995; 121(1):7-15. PubMed ID: 7860623
[TBL] [Abstract][Full Text] [Related]
14. [DCC and colorectal carcinogenesis].
Caca K; Zoller WG
Z Gastroenterol; 1997 Sep; 35(9):895-7. PubMed ID: 9432822
[No Abstract] [Full Text] [Related]
15. [Accumulation of genetic alterations during human tumor progression].
Yokota J; Ookawa K
Gan To Kagaku Ryoho; 1993 Feb; 20(3):321-5. PubMed ID: 8094949
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
18. DCC: linking tumour suppressor genes and altered cell surface interactions in cancer?
Cho KR; Fearon ER
Eur J Cancer; 1995; 31A(7-8):1055-60. PubMed ID: 7576991
[TBL] [Abstract][Full Text] [Related]
19. Should DCC be deleted as tumor-suppressor candidate?
Gastroenterology; 1997 Jul; 113(1):3. PubMed ID: 9207252
[No Abstract] [Full Text] [Related]
20. Tumor suppressor genes.
Anand A
Hosp Pract (Off Ed); 1993 Jan; 28(1):21. PubMed ID: 8419413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
